Schuelter-Trevisol, FabianaSchmitt, Graciane JacintaAraújo, Jane Martins deSouza, Liliane Braga deNazário, Juliana GomesJanuário, Raquel LanduchiMello, Rogério SobrozaTrevisol, Daisson José2019-08-052020-11-262019-08-052020-11-2620161678-984911https://repositorio.animaeducacao.com.br/handle/ANIMA/2622New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM- 1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.130-134en-USAttribution-NonCommercial-NoDerivs 3.0 BrazilAcinetobacterBeta-lactam resistanceMicrobial drug resistanceArtigo de Periodico